Oligodendroglioma

Oligodendrogliomas are a type of glioma that are believed to originate from the oligodendrocytes of the brain or from a glial precursor cell. They occur primarily in adults and are only rarely found in children . The median age of diagnosis for oligodendroglioma is 41 years of age. (From the Wikpedia article Oligodendroglioma.)

Download PDF

Recent Publications on Oligodendroglioma:
Anaplastic oligodendroglioma. Although uncommon, anaplastic oligodendrogliomas (AODs) are important to...	27th June, 2008	Jaishri Blakeley, MD Brain Cancer Program, Johns Hopkins University,	Curr Treat Options Neurol. 2008 Jul;10(4):295-307.
miR-124 and miR-137 inhibit proliferation of GBM cells and induce differentiation of brain tumor stem cells. ABSTRACT: BACKGROUND: Glioblastoma multiforme (GBM) is an invariably fatal...	26th June, 2008		BMC Med. 2008 Jun 24;6(1):14. DOI Direct Link
Leptomeningeal disease from oligodendroglioma: clinical and molecular analysis. BACKGROUND: Leptomeningeal disease (LMD) is a late complication of...	26th June, 2008	Department of Oncology, Tom Baker Cancer Centre, Alberta Cancer Board,	Can J Neurol Sci. 2008 May;35(2):204-9.
Familial occurrence of oligodendroglial tumours. Two non-identical brothers were diagnosed with anaplastic oligoastrocytoma...	24th June, 2008	Departments of Neurosurgery.	Br J Neurosurg. 2008 Jun;22(3):436-8. DOI Direct Link
[Diagnostic and prognostic values of 1p and 19q deletions in adult gliomas: critical review of the literature and implications in daily clinical practice.] Losses of chromosomes 1p and 19q are deemed correlated with diagnosis of...	21st June, 2008	Service de neurochirurgie, hopital Pasteur, CHU de Nice, UNSA, 30, avenue	Rev Neurol (Paris). 2008 June - July;164(6-7):595-604. Epub 2008 May 21. DOI Direct Link
→View more research publications.

BioNews Results for Oligodendroglioma:
Research in the area of biotechnology business reported from Amgen, Inc	Calibre Macro World:  Jun 26 2008 11:12PM Matching: oligodendroglioma
Use of biomolecular targets in the treatment and visualization of tumors	PharmCast:  May 22 2008 3:52AM Matching: oligodendroglioma

Oligodendroglioma Clinical Trials:
Natural History Study of Patients With Central Nervous System Tumors Being Evaluated at the National Institutes of Health	Brain and Central Nervous System Tumors;   Chordoma;   Neuroblastoma
Melphalan and Mannitol in Treating Patients With Central Nervous System Cancer	Brain and Central Nervous System Tumors;   Chordoma;   Lymphoma;   Von Hippel-Lindau Syndrome
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors	Adrenocortical Carcinoma;   Brain and Central Nervous System Tumors;   Head and Neck Cancer;   Liver Cancer;   Malignant Mesothelioma;   Pheochromocytoma;   Sarcoma
Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors	Malignant Intracranial Tumors;   Glioblastoma Multiforme;   Anaplastic Astrocytomas;   Anaplastic Oligodendrogliomas;   Anaplastic Ependymoma
A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas	Glioma Interventions: Drug: RTA 744;   Drug: RTA 744 injection
→View more trials.

Oligodendroglioma Patents:
US Patent No.	Title
7348149	Methods of diagnosing Parkinson's disease by measuring expression level of RNA encoding human protein HLLRCR-1
7358241	Compositions and methods comprising farnesyl dibenzodiazepinones for treating neoplastic cells and conditions
7358272	Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione
7358274	Methods for treating or preventing cancer using Benzopyranone Compounds
7361332	Treating tumors using implants comprising combinations of allogeneic cells
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Oligodendroglioma scientists - we have details of around 303 individuals working on Oligodendroglioma .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.